Idera Pharmaceuticals, Inc. (IDRA) To Participate In A Panel Discussion At The Piper Jaffray Genomerx Symposium
6/17/2014 1:23:06 PM
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleotide therapeutics for patients with cancer and orphan diseases, today announced that Sudhir Agrawal, D. Phil., Chief Executive Officer, will participate in a panel discussion entitled “RNA/DNA: Getting It Where You Need It” at the Piper Jaffray GenomeRx Symposium on Monday, June 23, 2014. The panel is scheduled to begin at 3:30 p.m. EDT and will take place in New York City.
Help employers find you! Check out all the jobs and post your resume.